The implantation of a balloon-expandable aortic valve without versus with prior BAV, although performed with a shorter procedure time and lower contrast volume, is associated with a significantly higher volume of cerebral ischemic lesions.
As compared to Sapien-3 29 mm the Evolut-R 34 mm is a real alternative for TAVR in patients with a large annulus with a comparable peri-procedural complication rate, better hemodynamic results but a trend for higher pacemaker rate.
Objective
To evaluate the risk for brain lesions in valve in valve (VIV)‐transcatheter aortic valve replacement (TAVR) compared to native valve procedures (NV‐TAVR).
Background
TAVR is associated with the risk of stroke and a high incidence of brain lesions in diffusion‐weighted magnetic resonance imaging (DW‐MRI). The risk in VIV procedures is unknown.
Methods
Patients were included, if they received a Sapien‐3 or an Evolut‐R valve for an NV‐TAVR or VIV‐TAVR and a DW‐MRI within 3–5 days after the procedure.
Results
Two hundred nine patients had NV‐TAVR and 41 patients had VIV‐TAVR.
The VIV group was significantly younger (mean 82.3 vs. 74.7 years old, p < .001) but had higher mean EuroSCORE II (4.8 vs. 7.8, p < .001).
Predilatation was significantly more common with native valve (39% vs. 2%, p < .01), postdilatation rate was lower in VIV but without statistical significance (17% vs. 7%, p = .110).
Combined in‐hospital safety outcome was comparable [13(6.6%) vs. 5(12.2%), p = .205]. Any stroke was documented in four (0.5%) patients after native valve and in one (2.4%) after VIV‐TAVR.
New DW‐MRI brain lesions were significantly more often found in patients with native valves [153(73.2%) vs. 21(51.2%), p = .005], mean number of new lesions was also higher with native valve (2.8 ± 3.2 vs. 1.0 ± 1.4, p < .001).
Forward stepwise of logistic regression found age and post dilatation significant predictors of new MRI lesions.
Conclusions
Compared to native valves, VIV procedures were associated with lower incidence and number of brain lesions according to DW‐MRI; these were explained by lower patients' age and lower rate of postdilatation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.